Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.51387 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.47648 | 58 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.47685 | 58 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.4501 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.44617 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.52943 | 57 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.47476 | 55 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.45197 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.45044 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.46705 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.45963 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.43361 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.47332 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.46586 | 57 |